A detailed history of Riverview Trust CO transactions in Incyte Corp stock. As of the latest transaction made, Riverview Trust CO holds 11 shares of INCY stock, worth $822. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11
Holding current value
$822
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$57.33 - $68.61 $630 - $754
11 New
11 $0
Q1 2024

Apr 12, 2024

BUY
$56.55 - $66.59 $29,179 - $34,360
516 New
516 $29,000
Q1 2022

Apr 21, 2022

BUY
$66.02 - $79.71 $19,607 - $23,673
297 New
297 $24,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Riverview Trust CO Portfolio

Follow Riverview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.